1.Date of the board of directors resolution:2021/12/20
2.Name and title of the managerial officer with
permission to engage in competitive conduct:
President, Min Liang Kuo
3.Items of competitive conduct in which the officer is
permitted to engage:
Representative juristic-person director of Microbio (Shanghai) Co., Ltd.
4.Period of permission to engage in the competitive
conduct:
Within period serving as the manager in the Company.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 32 of the
Company Act):
Approved without objection by the directors present.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
title of the managerial officer (if it is not the
operator of a mainland China enterprise, please enter
“N/A” below):
President, Min Liang Kuo
7.Company name of the mainland China enterprise and the
officer’s position in the enterprise:
Representative juristic-person director of Microbio (Shanghai) Co., Ltd.
8.Address of the mainland China enterprise:
1188 Guangxing Road, Songjiang District, Shanghai
9.Operations of the mainland China enterprise:
Drug production, drug commissioned production, drug wholesale, medicine,
food,technology development in the field of health science and technology,
technology transfer, technical consultation, and technical service.
10.Impact on the company’s finance and business:
Microbio (Shanghai) is a subsidiary of Microbio and its profits or
losses is recognized by equity method.
11.If the managerial officer or director has invested in
the mainland China enterprise, the monetary amount of the
investment and the officer or director’s shareholding ratio:
(1)Investment amount: USD$50,000
(2)Shareholding ratio: 0.0954%
12.Any other matters that need to be specified:None
Announcement of the BOD resolved to release of non-compete restrictions for the manager
